These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 22981148

  • 1. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
    Titan SM, Vieira JM, Dominguez WV, Moreira SR, Pereira AB, Barros RT, Zatz R.
    J Diabetes Complications; 2012; 26(6):546-53. PubMed ID: 22981148
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 3. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC, Collaborative Study Group.
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [Abstract] [Full Text] [Related]

  • 4. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY.
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [Abstract] [Full Text] [Related]

  • 5. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 6. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH.
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [Abstract] [Full Text] [Related]

  • 7. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [Abstract] [Full Text] [Related]

  • 8. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [Abstract] [Full Text] [Related]

  • 9. Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria.
    Lorenzo V, Saracho R, Zamora J, Rufino M, Torres A.
    Nephrol Dial Transplant; 2010 Mar; 25(3):835-41. PubMed ID: 19762600
    [Abstract] [Full Text] [Related]

  • 10. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Mar; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P, Eiam-Ong S, Suwanwalaikorn S.
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [Abstract] [Full Text] [Related]

  • 12. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM, Bondor CI, Kacso G.
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study.
    Verhave JC, Bouchard J, Goupil R, Pichette V, Brachemi S, Madore F, Troyanov S.
    Diabetes Res Clin Pract; 2013 Sep; 101(3):333-40. PubMed ID: 23880038
    [Abstract] [Full Text] [Related]

  • 14. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.
    Ellis D, Forrest KY, Erbey J, Orchard TJ.
    Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 16. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 17. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A.
    Nephrol Dial Transplant; 1996 Mar 21; 11(3):449-56. PubMed ID: 8671814
    [Abstract] [Full Text] [Related]

  • 18. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS.
    Kidney Int; 2018 May 21; 93(5):1198-1206. PubMed ID: 29398132
    [Abstract] [Full Text] [Related]

  • 19. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B, Cheekatla S, Aggarwal A.
    Lupus; 2013 May 21; 22(6):614-23. PubMed ID: 23629827
    [Abstract] [Full Text] [Related]

  • 20. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H, DNETT-Japan Study Group.
    Diabetes Res Clin Pract; 2010 Feb 21; 87(2):228-32. PubMed ID: 19889469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.